Liquiritin Protects Against Cardiac Fibrosis After Myocardial Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway [Letter].
Hasta Handayani Idrusnull SunarnoPublished in: Drug design, development and therapy (2023)